Alpine Immune Sciences Inc (NASDAQ:ALPN)

10.55
BATS BZX Real-Time Price
As of 12:32pm ET
 -0.18 / -1.68%
Today’s Change
2.05
Today|||52-Week Range
15.00
+174.74%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$197.1M

Company Description

Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company. The firm engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded in 2015 and is headquartered in Seattle, WA.

Contact Information

Alpine Immune Sciences, Inc.
188 East Blaine Street
Seattle Washington 98102
P:(206) 788-4545
Investor Relations:

Employees

Shareholders

Individual stakeholders54.12%
Other institutional28.52%
Mutual fund holders1.51%

Top Executives

Mitchell H. GoldExecutive Chairman & Chief Executive Officer
Stanford L. PengPresident & Head-Research & Development
Thaedra ThullberryFinance Director
James Paul RickeyChief Financial Officer & Senior Vice President
Kristine SwiderekSenior Vice President-Research